Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NGEN | ||||
| Company | Nervgen Pharma Corp | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 3.93 | ||||
| High | 3.93 | ||||
| Low | 3.65 | ||||
| Latest | 3.66 | ||||
| Change | -0.25 | ||||
| % Change | -6.39% | ||||
| Volume | 114,400 | ||||
| 20-Day Average Volume | 116,185 | ||||
| Previous Close | 3.91 | ||||
| Industry | N/A | ||||
| Has Options | Yes | ||||
| Technicals | |||||
| 20-Day Moving Average | 3.96 | ||||
| 20-Day Raw Stochastic | 13.10% | ||||
| 20-Day Relative Strength | 41.08 | ||||
| Weighted Alpha | +41.25 | ||||
| Today's Opinion | 8% Sell | ||||
| Previous Opinion | 8% Buy | ||||
| Last Month's Opinion | 56% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.81% since 03/19/26 | ||||
| Low | 3.65 on 03/26/26 | ||||
| High | 4.04 on 03/20/26 | ||||
| 1-Month | |||||
| %Chg | -12.44% since 02/26/26 | ||||
| Low | 3.55 on 03/13/26 | ||||
| High | 4.39 on 03/04/26 | ||||
| 3-Month | |||||
| %Chg | -32.32% since 12/26/25 | ||||
| Low | 3.55 on 03/13/26 | ||||
| High | 6.30 on 01/08/26 | ||||
| 6-Month | |||||
| %Chg | +55.74% since 09/26/25 | ||||
| Low | 2.28 on 11/06/25 | ||||
| High | 6.30 on 01/08/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 46,920,000 | ||||
| Annual Net Income | -38,100,000 | ||||
| Last Quarter Sales | 0 | ||||
| Last Quarter Net Income | -4,156,070 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/24/25 | ||||
| Latest Earnings Date | 12/31/69 | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||